VEGF antagonist formulations suitable for intravitreal administration | Patent Number 11066458

US 11066458 B2
Application Number16582486
Publication NumberUS 20200017572 A1
Pendency1 year, 9 months, 29 days
Filled DateSep 25, 2019
Priority DateJun 16, 2006
Publication DateJan 16, 2020
Expiration DateJun 15, 2026
Inventor/ApplicantsDaniel DIX
Kelly Frye
Kelly FRYE
Daniel Dix
Eric Furfine
Kenneth Graham
Kenneth GRAHAM
Eric FURFINE
ExaminesLOCKARD, JON MCCLELLAND
Art Unit1647
Technology Center1600
Assignments
Regeneron Pharmaceuticals
Current
Regeneron Pharmaceuticals
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.